BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse initiates coverage on Apollo Hospital with outperform
Apollo is attractively placed versus Asian peers. Company has strong growth visibility and proven execution capabilities. Company is likely to sustain 18 per cent five-year ebitda compound annual growth rate. Risk-reward is favourable with strong growth visibility.